Here is the keystone for previous announcements -Pre MT , which was described recently as the Dark Ages
Last years AGM ASX Announcement was clear , K9 Commercial Outcome 2023
July 4c
Corporate outcome targeted CY23 on the licensing or sale of MPL’s vet cancer
applications following commercially valuable Phase 2 outcomes
July K9 Update
The negotiations to date are consistent with the Company’s strategy of the licensing or
sale of MPL’s vet cancer applications following commercially valuable Phase 2 outcomes.
and the announcement that was Licensing or outright sale of the K9 Oncology Treatment .... to late on a Friday to look up the date
Big Week coming , AGM plus CEO MT and PI Mathers to present plus PAA are Silver Sponsors of the Event so that should deliver some great opportunities to "spread the word"
Hope everyone has a relaxing weekend with friends and family ,,NZT
- Forums
- ASX - By Stock
- PAA
- Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing
Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing, page-125
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
18.0¢ |
Change
0.005(2.86%) |
Mkt cap ! $87.55M |
Open | High | Low | Value | Volume |
18.0¢ | 18.0¢ | 17.5¢ | $36.85K | 205.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 162181 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 412357 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 162181 | 0.175 |
13 | 401984 | 0.170 |
7 | 256513 | 0.165 |
8 | 396304 | 0.160 |
7 | 336735 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 412357 | 6 |
0.185 | 267471 | 5 |
0.190 | 772743 | 8 |
0.195 | 540777 | 9 |
0.200 | 302726 | 11 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
NEWS
Exceptional lithium assays uncovered at Falcon Lake – expanding mineralisation, big potential ahead
NEWS
Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
PAA (ASX) Chart |